Carregant...

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-06-01
Col·lecció:Journal of Clinical Medicine
Matèries:
HHT
Accés en línia:https://www.mdpi.com/2077-0383/9/6/1766
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!